前列腺放疗的稳健优化:纳入分次内前列腺位置偏差评估实际递送剂量
该回顾性研究分析20例局限期前列腺癌患者的放疗及实时前列腺位置数据,对比基于计划靶体积(PTV)与稳健优化两种容积旋转调强计划的实际递送剂量。稳健优化较PTV计划降低膀胱V40和V60,但两种方法的临床靶体积(CTV)剂量准确性无差异。
要点
- 稳健优化较PTV计划降低膀胱V40和V60均值分别约5.2%和5.1%。
- 校正位置偏差时,两种计划CTV D99均值差异均为0.1 Gy。
- 未校正时,PTV计划与稳健优化CTV D99分别降低0.1 Gy和0.2 Gy。
核心结论
- 稳健优化较PTV计划降低膀胱V40和V60,但两种方法的CTV剂量准确性无差异。
研究设计与样本
- 回顾性分析20例前列腺癌患者的放疗及实时前列腺位置数据。
- 每例患者生成PTV计划和稳健优化两组容积旋转调强计划,PTV计划采用7 mm CTV-PTV外扩,稳健计划考虑相同幅度的位置偏差。
- 利用本院位置监测系统确定靶区位置,在校正与未校正位置偏差两种场景下评估递送剂量。
主要发现
- 稳健优化较PTV计划,膀胱V40均值(标准差)降低5.2%(4.1%),膀胱V60降低5.1%(1.9%)。
- 稳健优化较PTV计划,直肠V40降低0.8%(0.5%),直肠V60降低0.6%(0.6%)。
- 校正场景下,两种计划CTV D99均值(标准差)差异均为0.1 Gy(0.1 Gy)。
- 未校正场景下,PTV计划CTV D99降低0.1 Gy(0.5 Gy),稳健优化降低0.2 Gy(0.6 Gy)。
- 校正与未校正场景下,两种计划直肠和膀胱剂量均无统计学显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the robustness of the dose delivered to the clinical target volume (CTV) between planning target volume (PTV)-based and robust optimization planning approaches in localized prostate cancer radiation therapy. METHODS AND MATERIALS: Retrospective data of 20 patients with prostate cancer, including radiation therapy and real-time prostate position, were analyzed. Two sets of volumetric modulated arc therapy plans were generated per patient: PTV-based and robust optimization. PTV-based planning used a 7-mm CTV-PTV margin, whereas robust planning considered same-magnitude position deviations. Differences in CTV dose delivered to 99% volume (D99), PTV dose delivered to 95% volume (D95), and bladder and rectum V40 (volume receiving 40 Gy) and V60 (volume receiving 60 Gy) values were evaluated. The target position, determined by in-house position monitoring system, was incorporated for dose assessment with and without position deviation correction. RESULTS: In the robust optimization approach, compared with PTV-based planning, the mean (standard deviation) V40 and V60 values of the bladder were reduced by 5.2% (4.1%) and 5.1% (1.9%), respectively. Similarly, for the rectum, the reductions were 0.8% (0.5%) and 0.6% (0.6%). In corrected treatment scenarios, both planning approaches resulted in a mean (standard deviation) CTV D99 difference of 0.1 Gy (0.1 Gy). In the not corrected scenario, PTV-based planning reduced CTV D99 by 0.1 Gy (0.5 Gy), whereas robust planning reduced it by 0.2 Gy (0.6 Gy). There was no statistically significant difference observed in the planned and delivered rectum and bladder dose for both corrected and not corrected scenarios. CONCLUSIONS: Robust optimization resulted in lower V40 and V60 values for the bladder compared with PTV-based planning. However, no difference in CTV dose accuracy was found between the 2 approaches.
引用
- Arumugam S, Sidhom M. Robust Optimization for Prostate Radiation Therapy: Assessment of Delivered Dose by Incorporating Intrafraction Prostate Position Deviations. Adv Radiat Oncol. 2024. PMID: 38596454. doi:10.1016/j.adro.2024.101455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。